Kyto Technology & Life Science, Inc. - FORM 10-K - EX-32.1 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 - June 29, 2016

Attached files

file filename
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF THE SARBANES-OXLY ACT OF 2002 - Kyto Technology & Life Science, Inc.kbph_ex311.htm
10-K - ANNUAL REPORT - Kyto Technology & Life Science, Inc.kbph_10k.htm
 
 
EXHIBIT 32.1
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED
 
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
Pursuant to Section 905 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), I, Georges Benarroch, President, Chief Executive Officer and Acting Chief Financial Officer of Kyto Biopharma, Inc., a Florida corporation (the "Company"), do hereby certify, to the best of my knowledge, that:
 
(1)
The Company's Annual Report on Form 10-K for the period ended March 31, 2016, as filed with the Securities Exchange Commission on the date hereof (the "Report") fully complies, in all material respects, with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
 
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.
 
 
 
 
 
 
 
 
 
Date:  June 29, 2016
By:
  /s/ Georges Benarroch
 
 
 
Georges Benarroch
 
 
 
President, Chief Executive Officer, principal executive officer, principal financial and accounting officer
 
 
 
 
 
   
                                                              
 

Kyto Technology & Life Science, Inc. Reports